Biocon Share Price
402.10+0.10 (+0.02%)
+11.22% past 1 Year
News
Biocon to host analyst and institutional investor meet on September 4, 2026
Equity
BIOCON
True North plans Rs 700 crore secondary stake sale in Biocon
Equity
BIOCON
Biocon receives Japan approval for pegfilgrastim biosimilar
Equity
BIOCON
Bernstein upgrades Biocon on US FDA nod for Yesintek autoinjectors
Equity
BIOCON
Biocon secures US FDA approval for Yesintek autoinjector formulation
Equity
BIOCON
Citi reiterates Sell on Biocon after 1QFY27 revenue and margin miss
Equity
BIOCON
Biocon Underperform Maintained by Bernstein After Q1 Revenue and EBITDA Growth
Equity
BIOCON
Jefferies holds Biocon with reduced estimates after weak quarter
Equity
BIOCON
HSBC maintains Buy on Biocon with Rs 490 target price
Equity
BIOCON
Biocon expects Syngene International to perform well from October to March
Equity
BIOCON
Biocon expects strong ramp-up in aflibercept biosimilar from H2 FY growth
Equity
BIOCON
Biocon concall highlights GLP-1 portfolio as key future growth driver
Equity
BIOCON
Biocon expands European manufacturing footprint to strengthen regional supply chain
Equity
BIOCON
Biocon reports stronger Q1 EBITDA and margin improvement on yearly basis
Equity
BIOCON
Biocon posts year-on-year revenue growth in Q1 FY2026 earnings update
Equity
BIOCON
Biocon reports sharp rise in first quarter net profit to Rs 141 crore
Equity
BIOCON
Biocon Receives Health Canada Approval for Yesintak Ustekinumab Autoinjector Pen
Equity
BIOCON
Biocon Malaysia unit secures EMA nod for new insulin production facility
Equity
BIOCON
Dam Capital reiterates Buy on Biocon, sets Rs 495 target price
Equity
BIOCON
Biocon underperform rating retained; Bernstein sets Rs 326 target post Viatris exit
Equity
BIOCON